• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺病毒纯化工艺的开发:控制病毒聚集以提高宿主细胞DNA的清除率

Development of a purification process for adenovirus: controlling virus aggregation to improve the clearance of host cell DNA.

作者信息

Konz John O, Lee Ann L, Lewis John A, Sagar Sangeetha L

机构信息

Biologics Development & Engineering and Live Viral Vectors, BioProcess R&D, Merck Research Laboratories, West Point, Pennsylvania 19486, USA.

出版信息

Biotechnol Prog. 2005 Mar-Apr;21(2):466-72. doi: 10.1021/bp049644r.

DOI:10.1021/bp049644r
PMID:15801787
Abstract

The clearance of host cell DNA is a critical goal for purification process development for recombinant Ad5 (rAd5) based vaccines and gene therapy products. We have evaluated the clearance of DNA by a rAd5 purification process utilizing nuclease digestion, ultrafiltration, and anion exchange (AEX) chromatography and found residual host cell DNA to consistently reach a limiting value of about 100 pg/10(11) rAd5 particles. Characterization of the purified rAd5 product using serial AEX chromatography, hydroxyapatite chromatography, or nuclease treatment with and without particle disruption showed that the residual DNA was associated with virus particles. Using a variety of additional physical characterization methods, a population of rAd5 virus in an aggregated state was detected. Aggregation was eliminated using nonionic detergents to attenuate hydrophobic interactions and sodium chloride to attenuate electrostatic interactions. After implementation of these modifications, the process was able to consistently reduce host cell DNA to levels at or below 5 pg/10(11) rAd5 particles, suggesting that molecular interactions between cellular DNA and rAd5 are important determinants of process DNA clearance capability and that the co-purifying DNA was not encapsidated.

摘要

清除宿主细胞DNA是基于重组腺病毒5型(rAd5)的疫苗和基因治疗产品纯化工艺开发的关键目标。我们评估了一种利用核酸酶消化、超滤和阴离子交换(AEX)色谱的rAd5纯化工艺对DNA的清除效果,发现残留的宿主细胞DNA始终达到约100 pg/10¹¹个rAd5颗粒的极限值。使用连续AEX色谱、羟基磷灰石色谱或在有或无颗粒破坏情况下进行核酸酶处理对纯化的rAd5产品进行表征,结果表明残留DNA与病毒颗粒相关。使用多种其他物理表征方法,检测到一群处于聚集状态的rAd5病毒。使用非离子去污剂减弱疏水相互作用,使用氯化钠减弱静电相互作用,从而消除了聚集现象。实施这些改进后,该工艺能够持续将宿主细胞DNA降低到5 pg/10¹¹个rAd5颗粒或更低水平,这表明细胞DNA与rAd5之间的分子相互作用是工艺DNA清除能力的重要决定因素,并且共纯化的DNA未被包裹。

相似文献

1
Development of a purification process for adenovirus: controlling virus aggregation to improve the clearance of host cell DNA.腺病毒纯化工艺的开发:控制病毒聚集以提高宿主细胞DNA的清除率
Biotechnol Prog. 2005 Mar-Apr;21(2):466-72. doi: 10.1021/bp049644r.
2
Development of a novel adenovirus purification process utilizing selective precipitation of cellular DNA.利用细胞DNA选择性沉淀开发新型腺病毒纯化工艺。
Biotechnol Bioeng. 2005 Jul 5;91(1):12-21. doi: 10.1002/bit.20406.
3
Purification of adenoviral vectors by combined anion exchange and gel filtration chromatography.腺病毒载体的联合阴离子交换和凝胶过滤层析纯化。
J Gene Med. 2009 Nov;11(11):978-89. doi: 10.1002/jgm.1383.
4
Improved purification of recombinant adenoviral vector by metal affinity membrane chromatography.通过金属亲和膜色谱法改进重组腺病毒载体的纯化
Biochem Biophys Res Commun. 2009 Jan 16;378(3):640-4. doi: 10.1016/j.bbrc.2008.11.096. Epub 2008 Dec 3.
5
Rapid high-performance liquid chromatographic analysis of adenovirus type 5 particles with a prototype anion-exchange analytical monolith column.使用原型阴离子交换分析整体柱对5型腺病毒颗粒进行快速高效液相色谱分析。
J Chromatogr A. 2009 Mar 27;1216(13):2725-9. doi: 10.1016/j.chroma.2008.11.010. Epub 2008 Nov 11.
6
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.六邻体嵌合5型腺病毒载体可规避预先存在的抗载体免疫。
Nature. 2006 May 11;441(7090):239-43. doi: 10.1038/nature04721. Epub 2006 Apr 16.
7
Scaleable purification of adenovirus vectors.腺病毒载体的可扩展纯化
Methods Mol Biol. 2008;434:13-23. doi: 10.1007/978-1-60327-248-3_2.
8
A new scalable method for the purification of recombinant adenovirus vectors.一种用于纯化重组腺病毒载体的新型可扩展方法。
Hum Gene Ther. 2002 Nov 1;13(16):1921-34. doi: 10.1089/10430340260355338.
9
Accelerated purification process development of monoclonal antibodies for shortening time to clinic. Design and case study of chromatography processes.加速单克隆抗体纯化工艺开发以缩短临床应用时间。色谱法工艺的设计与案例研究。
J Chromatogr A. 2007 Dec 28;1176(1-2):149-56. doi: 10.1016/j.chroma.2007.10.104. Epub 2007 Nov 7.
10
Densonucleosis virus purification by ion exchange membranes.通过离子交换膜纯化登革病毒。 (注:原文中“Densonucleosis virus”可能有误,推测应为“Dengue virus”,登革病毒,按照纠正后的内容翻译。若原文无误,“Densonucleosis virus”可直译为“浓核症病毒” )
Biotechnol Bioeng. 2004 Nov 20;88(4):465-73. doi: 10.1002/bit.20270.

引用本文的文献

1
Enhanced Downstream Processing for a Cell-Based Avian Influenza (H5N1) Vaccine.基于细胞的禽流感(H5N1)疫苗的强化下游加工
Vaccines (Basel). 2024 Jan 29;12(2):138. doi: 10.3390/vaccines12020138.
2
Evaluation of the Robustness Verification of Downstream Production Process for Inactivated SARS-CoV-2 Vaccine and Different Chromatography Medium Purification Effects.新型冠状病毒灭活疫苗下游生产工艺稳健性验证及不同色谱介质纯化效果评估
Vaccines (Basel). 2024 Jan 6;12(1):56. doi: 10.3390/vaccines12010056.
3
Serum-free lentiviral vector production is compatible with medium-resident nuclease activity arising from adherent HEK293T host cells engineered with a nuclease-encoding transgene.
无血清慢病毒载体生产与用编码核酸酶的转基因工程改造的贴壁HEK293T宿主细胞产生的中等水平核酸酶活性兼容。
Heliyon. 2023 Jun 7;9(6):e17067. doi: 10.1016/j.heliyon.2023.e17067. eCollection 2023 Jun.
4
Incubation Temperature and Period During Denarase Treatment and Microfiltration Affect the Yield of Recombinant Adenoviral Vectors During Downstream Processing.在去唾液酸酶处理和微滤过程中,孵育温度和时间会影响下游处理过程中重组腺病毒载体的产量。
Mol Biotechnol. 2023 Jul;65(7):1129-1139. doi: 10.1007/s12033-022-00616-8. Epub 2022 Nov 30.
5
Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective.腺病毒载体在心血管基因治疗中的应用:临床和产业视角。
J Mol Med (Berl). 2022 Jun;100(6):875-901. doi: 10.1007/s00109-022-02208-0. Epub 2022 May 24.
6
Evaluation of Host Cell Impurity Effects on the Performance of Sterile Filtration Processes for Therapeutic Viruses.宿主细胞杂质对治疗性病毒无菌过滤工艺性能的影响评估。
Membranes (Basel). 2022 Mar 24;12(4):359. doi: 10.3390/membranes12040359.
7
Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate.评价一种从细胞培养中回收和浓缩 rVSV-Spike COVID-19 疫苗候选物的下游工艺。
Vaccine. 2021 Nov 26;39(48):7044-7051. doi: 10.1016/j.vaccine.2021.10.045. Epub 2021 Oct 22.
8
A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation.在 CsCl 梯度超速离心过程中对溶瘤腺病毒 Ad5-delta-24-RGD 聚集的新认识。
Sci Rep. 2021 Aug 9;11(1):16088. doi: 10.1038/s41598-021-94573-y.
9
Neuroinvasiveness of the MR766 strain of Zika virus in IFNAR-/- mice maps to prM residues conserved amongst African genotype viruses.寨卡病毒 MR766 株在 IFNAR-/- 小鼠中的神经侵袭性与非洲基因型病毒中保守的 prM 残基有关。
PLoS Pathog. 2021 Jul 26;17(7):e1009788. doi: 10.1371/journal.ppat.1009788. eCollection 2021 Jul.
10
Lentiviral Vector Bioprocessing.慢病毒载体生物工艺。
Viruses. 2021 Feb 9;13(2):268. doi: 10.3390/v13020268.